Search research articles
Contact Us
Filters
Showing results (11-20 of 19,978) with videos related to
Page
of 1,998
Sort By:
Journal of Medicinal Chemistry
|
February 1, 1978
[1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin
M Manning, J Lowbridge, J Seto, et al.
Journal of Medicinal Chemistry
|
November 1, 1983
Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4
M Manning, A Olma, W A Klis, et al.
Journal of the American College of Cardiology
|
November 26, 2002
Value of precardioversion transesophageal echocardiography in managing cardioversion in atrial fibrillation
Warren J Manning, David I Silverman, Todd B Seto, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
December 10, 1999
When the body and appendage of the left atrium disagree: "Focal" atrial fibrillation-implications for atrial thrombus formation and risk of thromboembolism
T B Seto, W A Buchholz, P S Douglas, et al.
Journal of Medicinal Chemistry
|
June 1, 1981
Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin
M Manning, B Lammek, A M Kolodziejczyk, et al.
Journal of Medicinal Chemistry
|
April 1, 1982
Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism
M Manning, W A Klis, A Olma, et al.
Journal of Medicinal Chemistry
|
January 1, 1989
2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists
B Lammek, K Bankowski, A Misicka, et al.
Journal of Medicinal Chemistry
|
April 1, 1980
[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressin
M Kruszynski, B Lammek, M Manning, et al.
Circulation
|
July 18, 2002
Impact of a specific echocardiographic report comment regarding endocarditis prophylaxis on compliance with American Heart Association recommendations
Gregory P Sanders, Susan B Yeon, Jason Grunes, et al.
JAMA
|
June 29, 2000
Physicians' recommendations to patients for use of antibiotic prophylaxis to prevent endocarditis
T B Seto, D Kwiat, D A Taira, et al.
Page
of 1,998
Search research articles
Search
Showing results (11-20 of 19,978) with videos related to
Sort By:
Page
of 1,998
Journal of Medicinal Chemistry
|
February 1, 1978
[1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin
M Manning, J Lowbridge, J Seto, et al.
Journal of Medicinal Chemistry
|
November 1, 1983
Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4
M Manning, A Olma, W A Klis, et al.
Journal of the American College of Cardiology
|
November 26, 2002
Value of precardioversion transesophageal echocardiography in managing cardioversion in atrial fibrillation
Warren J Manning, David I Silverman, Todd B Seto, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
December 10, 1999
When the body and appendage of the left atrium disagree: "Focal" atrial fibrillation-implications for atrial thrombus formation and risk of thromboembolism
T B Seto, W A Buchholz, P S Douglas, et al.
Journal of Medicinal Chemistry
|
June 1, 1981
Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin
M Manning, B Lammek, A M Kolodziejczyk, et al.
Journal of Medicinal Chemistry
|
April 1, 1982
Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism
M Manning, W A Klis, A Olma, et al.
Journal of Medicinal Chemistry
|
January 1, 1989
2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists
B Lammek, K Bankowski, A Misicka, et al.
Journal of Medicinal Chemistry
|
April 1, 1980
[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressin
M Kruszynski, B Lammek, M Manning, et al.
Circulation
|
July 18, 2002
Impact of a specific echocardiographic report comment regarding endocarditis prophylaxis on compliance with American Heart Association recommendations
Gregory P Sanders, Susan B Yeon, Jason Grunes, et al.
JAMA
|
June 29, 2000
Physicians' recommendations to patients for use of antibiotic prophylaxis to prevent endocarditis
T B Seto, D Kwiat, D A Taira, et al.
Page
of 1,998